Ayvens: Integration proceeding well and Q1 2024 financial results in line with plans
GlobeNewswire
Q1 2024 RESULTS
*Leasing contract and Services margins *at EUR 706.6 million, up 30.6% vs. Q1 2023, driven by the..
Detachment 88
News and Video Search Results
News coverage
-
Societe Generale: First quarter 2024 earnings
GlobeNewswire
-
Casino Group: Availability of the prospectus
GlobeNewswire
-
Tonner Drones launches a capital increase with shareholders' preferential subscription rights for an amount of €5.0 million
GlobeNewswire
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
0 shares
1 views
You might like
Detachment 88 media coverage
Ayvens reports FY 2023 results
GlobeNewswire
Press release
Ayvens^1 reports FY 2023 results^2
Paris, 8 February 2024
FY 2023..
-
Storm Gladiator: How Russia Uses Recruited Convicts To Fight In ‘Fierce’ Assault Units In Ukraine – Analysis
Eurasia Review
-
EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
GlobeNewswire
-
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
GlobeNewswire
-
EYLEA® HD (aflibercept) Injection 8 mg Two-year Results from Pivotal PULSAR Trial in Wet Age-related Macular Degeneration Presented at EURETINA
GlobeNewswire
Advertisement
More coverage
Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma
Accesswire
*mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of distant metastasis or death by 65% (HR=0.347 [95% CI,..
-
Global Cell Dissociation Market Size Envisaged to Reach USD 1,161.06 Million By 2032, at 14.0% CAGR: Polaris Market Research
GlobeNewswire
-
Global Vitrectomy Machines Market to Reach $767.7 Million by 2030
GlobeNewswire
-
ONL Therapeutics to Report Clinical Data on ONL1204 in Podium Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
GlobeNewswire
-
Amundi: Financial year 2022
GlobeNewswire